3-dose of RBD vaccine is sufficient to elicit a long-lasting memory response against SARS-CoV-2 infection

• Mengqing Cong,
• Yunru Yang,
• Haiyang Tong,
• Ajmeri Sultana Shimu,
• Baolong Wang,
• Qing Li,
• Fengyin Li,
• Yi Yang,
• Tengchuan Jin,
• Bofeng Li

Affiliations

Mengqing Cong

Department of Medical Oncology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China

Yunru Yang

Department of Medical Oncology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China

Haiyang Tong

High Magnetic Field Laboratory, Hefei Institutes of Physical Science, Chinese Academy of Sciences

Ajmeri Sultana Shimu

Department of Medical Oncology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China

Baolong Wang

Department of Medical Oncology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China

Qing Li

Department of Medical Oncology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China

Fengyin Li

Department of Medical Oncology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China

Yi Yang

Zhuoyi Biotech Co. Ltd

Tengchuan Jin

Department of Medical Oncology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China

Bofeng Li

Department of Medical Oncology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China